Quarterly report · Q1
2370.TEDINET S100SUKD
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥248m | 2023-10-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥662m | 2022-10-01 → 2023-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥185m | 2022-10-01 → 2022-12-31 | Standalone | Net sales |
| Operating income | −¥294m | 2023-10-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | −¥325m | 2022-10-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | −¥292m | 2023-10-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥292m | 2023-10-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | −¥293m | 2023-10-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥326m | 2022-10-01 → 2022-12-31 | Standalone | Profit loss |
| Total assets | ¥6.3bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥5.6bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥5.5bn | at 2022-12-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥549m | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥590m | at 2023-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.8bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2022-12-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.0bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-1.2 | 2023-10-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.65 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.54 | 2022-10-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.3% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.2% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 253,510,757 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 232,160,757 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 211,730,423 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥147m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥56,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥56,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2023-10-01 → 2023-12-31 | −¥115m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2023-10-01 → 2023-12-31 | −¥32m |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥248m |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥248m |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | −¥147m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥161m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥107m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥57m |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | −¥164m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 307
| Item | Context | Value | Unit |
|---|---|---|---|
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2023-10-01 | |
| Current period end date | FilingDateInstant | 2023-12-31 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2022-10-01 | |
| Comparative period end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2023-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Material matters relating to going concern etc business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |